|
|
Market Analysis Reports of Deudextromethorphan
|
Schizophrenia - Pipeline Insight, 2021 ... approved drugs. AVP-786 is a combination of deudextromethorphan hydrobromide (d6-DM) and quinidine sulfate (Q), a CYP2D6 ...
NMDA receptor antagonists - Pipeline Insight, 2022 ... NP-120 (Ifenprodil) REL 1017 Lacosamide Deudextromethorphan AXS-05 SLS-002 Ketamine microneedle ...
Schizophrenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major schizophrenia markets reached a value of US$ 9,480.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 15,236.9 Million by 2034, exhibiting a growth rate (CAGR) of 4.4% during 2024-2034. The schizophrenia market has ...
|
|
|
|